Nordic Bioscience helps precision medicine development using the unique Protein Fingerprint biomarkers.

We are the only company in the world that provide extracellular matrix-focused collagen biomarkers that are able to distinguish between tissue formation and degradation.

By combining our biomarker technologies with our expertise in preclinical and clinical research, we can identify drug candidates most likely to benefit patients. The identification of predictive and prognostic biomarkers enriches clinical trials, which can reduce trial length and size of studies required to determine therapeutic efficacy.

Pharmacodynamics, response-to-treatment, mode-of-action investigation, and much more.

Our approach is highly scientific, and we are proud to publish our results frequently in leading journals worldwide.

Welcome to the Biomarker Powerhouse!

Please don't hesitate to contact us if you have any questions or other inquiries.

Nordic Bioscience provides tissue-derived Protein Fingerprint biomarkers, as well as neo-epitope biomarkers for evaluating pathological changes in all major disease areas.

Our biomarkers can be used individually or in combination to detect tissue formation, remodeling, or destruction.

More about us

Please don't hesitate to contact us if you have any questions or other inquiries.